HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Mariko Murata Selected Research

8-oxo-7-hydrodeoxyguanosine

1/2014Formation of the nitrative DNA lesion 8-nitroguanine is associated with asbestos contents in human lung tissues: a pilot study.
12/2013Inflammation-related DNA damage and expression of CD133 and Oct3/4 in cholangiocarcinoma patients with poor prognosis.
1/2012Role of nitrative and oxidative DNA damage in inflammation-related carcinogenesis.
10/2011Nitrative DNA damage and Oct3/4 expression in urinary bladder cancer with Schistosoma haematobium infection.
9/2011Nitrative and oxidative DNA damage caused by K-ras mutation in mice.
3/2008Urinary 8-oxo-7,8-dihydro-2'-deoxyguanosine in patients with parasite infection and effect of antiparasitic drug in relation to cholangiocarcinogenesis.
3/20068-Nitroguanine formation in oral leukoplakia, a premalignant lesion.
10/2005Procyanidin B2 has anti- and pro-oxidant effects on metal-mediated DNA damage.
9/2005Nitrative and oxidative DNA damage in oral lichen planus in relation to human oral carcinogenesis.
8/2005Nitrative and oxidative DNA damage in intrahepatic cholangiocarcinoma patients in relation to tumor invasion.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password:


Mariko Murata Research Topics

Disease

30Neoplasms (Cancer)
11/2015 - 05/2002
24Inflammation
01/2015 - 04/2002
9Cholangiocarcinoma
08/2015 - 09/2003
8Infection
12/2013 - 09/2003
4Urinary Bladder Neoplasms (Bladder Cancer)
01/2013 - 07/2002
3Breast Neoplasms (Breast Cancer)
10/2013 - 03/2004
3Leukemia
10/2010 - 10/2005
2Neurodegenerative Diseases (Neurodegenerative Disease)
01/2015 - 09/2011
2Squamous Cell Carcinoma (Epidermoid Carcinoma)
01/2015 - 09/2005
2Ischemia
06/2014 - 06/2009
2Lung Neoplasms (Lung Cancer)
01/2014 - 11/2004
2Nasopharyngitis
01/2014 - 06/2008
1Seasonal Allergic Rhinitis (Hay Fever)
01/2015
1Methemoglobinemia
09/2014
1Shock
06/2014
1Mesothelioma
01/2014
1Asthma (Bronchial Asthma)
11/2013
1Barrett Esophagus (Barrett's Esophagus)
05/2012
1Papilloma (Papillomatosis)
01/2012
1Cystitis
10/2011
1Adenocarcinoma
09/2011
1Dementia (Dementias)
09/2011
1Frontotemporal Dementia
09/2011
1Tauopathies
09/2011
1Colonic Neoplasms (Colon Cancer)
10/2010
1Communicable Diseases (Infectious Diseases)
08/2010
1Wounds and Injuries (Trauma)
01/2010
1Neoplasm Metastasis (Metastasis)
01/2010
1Rupture
06/2009
1Brain Ischemia (Cerebral Ischemia)
06/2009
1Parkinson Disease (Parkinson's Disease)
01/2009
1Neuroblastoma
01/2009
1Epstein-Barr Virus Infections
06/2008
1Malignant Fibrous Histiocytoma
11/2007
1Cervical Intraepithelial Neoplasia
07/2007
1Oral Leukoplakia
03/2006
1Leukoplakia
03/2006

Drug/Important Bio-Agent (IBA)

21DNA (Deoxyribonucleic Acid)IBA
01/2015 - 05/2002
188-nitroguanineIBA
01/2014 - 09/2003
138-oxo-7-hydrodeoxyguanosineIBA
01/2014 - 09/2003
7OxygenIBA
01/2015 - 09/2003
6NitrogenIBA
01/2015 - 09/2003
5Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA
01/2013 - 08/2004
4Nasopharyngeal carcinomaIBA
11/2015 - 06/2008
4Reactive Oxygen Species (Oxygen Radicals)IBA
03/2015 - 06/2009
4NF-kappa B (NF-kB)IBA
06/2008 - 09/2006
3Hydrogen Peroxide (Hydroperoxide)FDA LinkGeneric
08/2015 - 11/2003
3Biological Markers (Surrogate Marker)IBA
01/2015 - 03/2004
3Proteins (Proteins, Gene)IBA
01/2015 - 06/2009
3AsbestosIBA
01/2014 - 08/2010
3Estrogens (Estrogen)FDA Link
10/2013 - 03/2004
2Heat-Shock Proteins (Heat-Shock Protein)IBA
01/2015 - 04/2012
2heat-shock protein 70.1IBA
06/2014 - 04/2012
2Superoxide DismutaseIBA
12/2013 - 05/2012
2Cyclooxygenase 2 (Cyclooxygenase-2)IBA
01/2012 - 02/2007
23-nitrotyrosineIBA
09/2005 - 03/2004
2Proliferating Cell Nuclear Antigen (PCNA)IBA
08/2004 - 06/2004
1tebufenozide (Mimic)IBA
11/2015
1MelatoninIBA
03/2015
1MicroRNAs (MicroRNA)IBA
01/2015
1Carbon MonoxideIBA
01/2015
1Methylene Blue (Methylthioninium Chloride)FDA Link
09/2014
1Molecular Chaperones (Chaperone, Molecular)IBA
06/2014
1CXCR4 Receptors (CXCR4 Receptor)IBA
01/2014
1DNA Glycosylases (DNA Glycosylase)IBA
01/2014
1Serpentine Asbestos (Chrysotile)IBA
01/2014
18-hydroxyguanineIBA
01/2014
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2014
1Primary sclerosing cholangitisIBA
12/2013
1Keratin-19 (Keratin 19)IBA
12/2013
1Endocrine DisruptorsIBA
11/2013
1tributyltinIBA
11/2013
1GTP Phosphohydrolases (GTPases)IBA
10/2012
1Proton Pump InhibitorsIBA
05/2012
1Transferrin (beta 2 Transferrin)IBA
04/2012
1Transcription Factors (Transcription Factor)IBA
01/2012
1Dinoprostone (PGE2)FDA Link
01/2012
1tau Proteins (tau Protein)IBA
09/2011
1Amitrole (Aminotriazole)IBA
12/2010
1romidepsin (FK228)FDA Link
10/2010
1Cysteine (L-Cysteine)FDA Link
10/2010
1calf thymus DNAIBA
09/2010
1Immunologic Factors (Immunomodulators)IBA
08/2010
1PPAR alphaIBA
01/2010
1tissue-factor-pathway inhibitor 2 (PP5)IBA
01/2010
1Quaternary Ammonium Compounds (Ammonium)IBA
01/2010
1CalpainIBA
06/2009
1Caspase 3 (Caspase-3)IBA
01/2009
1norsalsolinolIBA
01/2009
1NeurotoxinsIBA
01/2009
1Cytochromes c (Cytochrome c)IBA
01/2009
1Membrane Proteins (Integral Membrane Proteins)IBA
06/2008
1CreatinineIBA
03/2008
1tranilast (N 5')IBA
07/2007
1Hair DyesIBA
09/2006
1Praziquantel (Biltricide)FDA Link
09/2006

Therapy/Procedure

1Heterologous Transplantation (Xenotransplantation)
11/2015
1Immunotherapy
01/2015
1Oral Administration
11/2013
1Therapeutics
11/2013